Mirum Pharmaceuticals, Inc. SEC filings MIRM
Mirum Pharmaceuticals, Inc. has 674 filings in SEC EDGAR's recent list, going back to Nov 20, 2018. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-3ASR | Automatic shelf registration | Feb 25, 2026 | — |
| S-8 | Employee stock plan registration | Feb 25, 2026 | — |
| S-8 | Employee stock plan registration | Sep 9, 2025 | — |
| S-3ASR | Automatic shelf registration | Aug 12, 2025 | — |
| S-8 | Employee stock plan registration | Feb 26, 2025 | — |
| S-8 | Employee stock plan registration | Mar 15, 2024 | — |
| S-8 | Employee stock plan registration | Nov 2, 2023 | — |
| 424B5 | Prospectus supplement | Nov 2, 2023 | — |
| S-3ASR | Automatic shelf registration | Oct 13, 2023 | — |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| S-3ASR | Automatic shelf registration | Sep 9, 2022 | — |
| 424B5 | Prospectus supplement | Aug 10, 2022 | — |
| 424B5 | Prospectus supplement | Aug 9, 2022 | — |
| S-3 | Shelf registration | May 25, 2022 | — |
| S-8 | Employee stock plan registration | Mar 9, 2022 | — |
| S-8 | Employee stock plan registration | Mar 9, 2021 | — |
| 424B5 | Prospectus supplement | Dec 15, 2020 | — |
| 424B5 | Prospectus supplement | Dec 14, 2020 | — |
| S-3/A | Filing | Aug 10, 2020 | — |
| S-3 | Shelf registration | Aug 3, 2020 | — |
| S-8 | Employee stock plan registration | May 7, 2020 | — |
| 424B4 | Prospectus | Jan 9, 2020 | — |
| S-1 | Registration statement | Jan 6, 2020 | — |
| S-8 | Employee stock plan registration | Aug 28, 2019 | — |
| 424B4 | Prospectus | Jul 18, 2019 | — |
| S-1/A | Amended registration statement | Jul 12, 2019 | — |
| S-1/A | Amended registration statement | Jul 8, 2019 | — |
| S-1 | Registration statement | Jun 21, 2019 | — |
Showing 28 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MIRM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Foster City, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1759425
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.